BNB Plus Corp. (BNBX) stock
Close on Oct 19, 2026Market cap $878.33KP/E –Yield –
BNB Plus Corp. saw revenue fall 1.3% to $2.39M over the twelve months to Jun 30, 2026. Free cash flow was -$12.56M. At the latest close the market valued the company at $878.33K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $878.33K
- P/E ratio
- –
- Price to sales
- 0.37
- Price to book
- 0.09
- Dividend yield
- –
- Free cash flow yield
- -1429.50%
Fundamentals
- Revenue
- $2.39M
- Net income
- -$35.22M
- EPS, diluted
- -$134.23
- Free cash flow
- -$12.56M
- Book value per share
- $1.13
- Diluted shares
- 8M
Trading
- Previous close
- $0.11
- Open
- $0.15
- Day's range
- $0.10 – $0.15
- Volume
- 64,396
- Average volume (20 days)
- 23,056
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | BNBX | S&P 500 | Difference | BNBX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -33.3% | +0.6% | −33.9 pts | ||
| 3 months | -12.1% | +3.4% | −15.5 pts | ||
| Year to date | -91.5% | +13.3% | −104.7 pts | ||
| 1 year | -97.0% | +16.6% | −113.6 pts | ||
| 3 years | -100.0% | +86.4% | −186.4 pts | -98.1% | +23.1% |
| 5 years | -100.0% | +81.9% | −181.9 pts | -93.4% | +12.7% |
| 10 years | -100.0% | +318.9% | −418.9 pts | -81.2% | +15.4% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases BNB Plus filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- News
About BNB Plus
Finance Services
BNB Plus Corp. operates as a digital asset treasury company focused on accumulating and managing BNB, the native cryptocurrency of the Binance blockchain ecosystem, to generate yield through staking, decentralized finance opportunities, and liquidity provision. In addition, the company develops and commercializes proprietary cell-free nucleic acid manufacturing technologies through its subsidiary, LineaRx, Inc. These solutions include synthetic DNA and engineered RNA polymerase platforms, specifically LineaDNA, LineaRNAP, and LineaIVT, which serve biopharmaceutical and diagnostic markets for the production of advanced biotherapeutics like mRNA treatments, gene therapies, and diagnostic tools.
Company profile, executives and historyBNB Plus stock: common questions
What is BNB Plus's stock price?
BNBX closed at $0.10 on Oct 19, 2026, down 6.67% on the day.
What is BNB Plus's market cap?
BNB Plus was worth $878.33K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is BNBX's P/E ratio?
BNB Plus lost money over fiscal 2025 (diluted EPS -$134.23), so it has no meaningful P/E ratio.
How much revenue does BNB Plus make?
BNB Plus reported revenue of $2.39M for the twelve months to Jun 30, 2026, down 1.3% from a year earlier.
Does BNB Plus pay a dividend?
No. BNB Plus has not paid a cash dividend over the last twelve months.
How has BNBX stock performed over the past year?
Including dividends, BNBX returned -97.0% over the past year, against +16.6% for the S&P 500.
Who are BNB Plus's competitors?
Companies most similar to BNB Plus by business, industry and size include SUIG, BNC, HYPD, ASST, FGC.
See a number that looks wrong?